These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 12660666

  • 1. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [Abstract] [Full Text] [Related]

  • 2. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.
    Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
    [Abstract] [Full Text] [Related]

  • 3. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 4. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective.
    Spencer F, Scleparis G, Goldberg RJ, Yarzebski J, Lessard D, Gore JM.
    Am Heart J; 2001 Oct; 142(4):594-603. PubMed ID: 11579348
    [Abstract] [Full Text] [Related]

  • 5. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
    Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S, Madsen M, Torp-Pedersen C.
    Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [Abstract] [Full Text] [Related]

  • 7. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):386-91. PubMed ID: 17568237
    [Abstract] [Full Text] [Related]

  • 8. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 11. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective.
    Goldberg RJ, Spencer FA, Steg PG, Flather M, Montalescot G, Gurfinkel EP, Kennelly BM, Goodman SG, Dedrick R, Gore JM, Global Registry of Acute Coronary Events Investigators.
    Arch Intern Med; 2007 Sep 10; 167(16):1766-73. PubMed ID: 17846396
    [Abstract] [Full Text] [Related]

  • 12. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H, Searles G, Gillis A.
    Can J Cardiol; 2001 Feb 10; 17(2):179-83. PubMed ID: 11223488
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term adherence with cardiovascular drug regimens.
    Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED.
    Am Heart J; 2006 Jan 10; 151(1):185-91. PubMed ID: 16368315
    [Abstract] [Full Text] [Related]

  • 16. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 10; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 17. Interventions to improve guideline compliance following coronary artery bypass grafting.
    Yam FK, Akers WS, Ferraris VA, Smith K, Ramaiah C, Camp P, Flynn JD.
    Surgery; 2006 Oct 10; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
    [Abstract] [Full Text] [Related]

  • 18. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug 10; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov 10; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.